Evidence map›Paper›PMID 41626608›Full record

ArticleBMJ public health2026

How do substance and polysubstance use trajectories differ by sexual attraction from ages 17 to 24? A community-based longitudinal cohort study in Switzerland.

Clarissa Janousch, Florian Vock, Babette L Winter, Tabea Hässler, Lukas Eggenberger, Laura Bechtiger, Michelle Loher, Tina Maria Binz, Markus R Baumgartner, Denis Ribeaud and 3 more

Abstract read
In one paragraph

Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Clarissa JanouschDepartment of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-4160-9758
Florian VockSwiss Aids Federation, Zürich, Switzerland.ORCID https://orcid.org/0009-0004-9916-7309
Babette L WinterDepartment of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0001-8293-9844
Tabea HässlerDepartment of Psychology, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-9371-2423
Lukas EggenbergerDepartment of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0003-3826-723X
Laura BechtigerJacobs Center for Productive Youth Development, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-7049-2165
Michelle LoherJacobs Center for Productive Youth Development, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-8669-7683
Tina Maria BinzZurich Institute of Forensic Medicine, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0001-6783-1202
Markus R BaumgartnerZurich Institute of Forensic Medicine, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-0979-931X
Denis RibeaudJacobs Center for Productive Youth Development, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-1668-8319
Manuel EisnerJacobs Center for Productive Youth Development, University of Zurich, Zürich, Switzerland.
Boris B Quednow *Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0001-7933-2865
Lilly Shanahan *Jacobs Center for Productive Youth Development, University of Zurich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-4534-6924

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Longitudinal, population-based studies of how youth substance use (SU) varies by sexual attraction, sex and their interaction remain scarce, especially in Europe. This study examines poly-SU (PSU) trajectories at 17, 20 and 24; disparities between sexual minority (SM) youth and heterosexual (HET) youth regarding these trajectories; and their correlates. Methods: We obtained data from the Zurich Project on Social Development from Childhood to Adulthood. SU was self-reported by n=1384 participants at 17, 20 and 24, and hair-tested at 20 and 24. Regression models included SM status, sex, their interaction, sociodemographic variables and psychosocial variables. This population-based longitudinal cohort analysis used linear mixed-effect models to examine developmental trajectories. Results: The proportion of SM youth increased from 11.3% at 17 to 23.4% at 24. At 20 and 24, SM were more likely than HET youth to have used cannabis, stimulants, ecstasy and hallucinogens in the past year. At 17, SM females reported high SU, which increased until 20, then plateaued or declined by 24, approaching those of HET males. SM males exhibited lower use at 17, but this sharply increased, reaching the highest levels by 24. HET females reported the lowest use. SM females had higher tobacco use, whereas SM males showed steep increases in alcohol, cannabis and stimulant use, surpassing all other groups regarding PSU by 24. Peer SU, low self-control, sensation-seeking and internalising symptoms predicted SU-related outcomes. Conclusions: Our findings on distinct developmental timing of the increases and escalation in SU highlight important opportunities for public health intervention, indicating that prevention efforts should be strategically timed and tailored to the unique escalation patterns observed among SM youth.

Indexed as

Community HealthDrug MonitoringMental HealthSexual Healthstatistics and numerical data

Identifiers

PMID41626608
PMCPMC12853546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.